Infection-induced apoptosis deletes bystander CD4+ T cells: A mechanism for suppression of autoimmunity during BCG infection

Journal of Autoimmunity

Volumn 24, Issue 2, 2005, Pages 93-100

  O'Connor, Richard A ^a   Wittmer, Susan ^a   Dalton, Dyana K ^a  

^a TRUDEAU INSTITUTE   (United States)

Author keywords

Apoptosis; EAE; Infection; Interferon gamma

Indexed keywords

BCG VACCINE; CD28 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; GAMMA INTERFERON;

ANIMAL CELL; ANTIGEN EXPRESSION; ANTIGENICITY; APOPTOSIS; ARTICLE; AUTOIMMUNITY; BACTERIAL INFECTION; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; DONOR; ENCEPHALOMYELITIS; GENETIC TRANSFECTION; HOST CELL; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; INTERMETHOD COMPARISON; MOUSE; NONHUMAN; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; T LYMPHOCYTE ACTIVATION; TRANSGENE;

EID: 17044419165     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaut.2005.01.005     Document Type: Article

References (34)

1. D.K. Dalton, L. Haynes, C.Q. Chu, S.L. Swain, and S. Wittmer Interferon gamma eliminates responding CD4 T cells during mycobacterial infection by inducing apoptosis of activated CD4 T cells J Exp Med 192 2000 117 122
2. +T cells to the lung airways during respiratory virus infections J Immunol 170 2003 1423 1429
3. B.J. Marsland, C.B. Scanga, M. Kopf, and G. Le Gros Allergic airway inflammation is exacerbated during acute influenza infection and correlates with increased allergen presentation and recruitment of allergen-specific T-helper type 2 cells Clin Exp Allergy 34 2004 1299 1306
4. H. Wekerle Immunology of the Nervous System 1997 Oxford University Press Oxford, England 460-92
5. A. Slavin, C. Ewing, J. Liu, M. Ichikawa, J. Slavin, and C.C. Bernard Induction of a multiple sclerosis-like disease in mice with an immunodominant epitope of myelin oligodendrocyte glycoprotein Autoimmunity 28 1998 109 120
6. J.H. Holda, D. Silberg, and R.H. Swanborg Autoimmune effector cells. IV. Induction of experimental allergic encephalomyelitis in Lewis rats without adjuvant J Immunol 130 1983 732 734
7. E. Bettelli, M. Pagany, H.L. Weiner, C. Linington, R.A. Sobel, and V.K. Kuchroo Myelin oligodendrocyte glycoprotein-specific T cell receptor transgenic mice develop spontaneous autoimmune optic neuritis J Exp Med 197 2003 1073 1081
8. Y. Refaeli, L. Van Parijs, S.I. Alexander, and A.K. Abbas Interferon gamma is required for activation-induced death of T lymphocytes J Exp Med 196 2002 999 1005
9. T.C. Martins, and A.P. Aguas Mechanisms of Mycobacterium avium-induced resistance against insulin-dependent diabetes mellitus (IDDM) in non-obese diabetic (NOD) mice: role of Fas and Th1 cells Clin Exp Immunol 115 1999 248 254
10. +T cells from human immunodeficiency virus-infected asymptomatic individuals J Exp Med 175 1992 331 340
11. J.C. Merrick, B.T. Edelson, V. Bhardwaj, P.E. Swanson, and E.R. Unanue Lymphocyte apoptosis during early phase of Listeria infection in mice Am J Pathol 151 1997 785 792
12. +T cells adoptively transferred into recipient mice after challenge with homologous parasite Proc Natl Acad Sci U S A 95 1998 1715 1720
13. J.M. McNally, C.C. Zarozinski, M.Y. Lin, M.A. Brehm, H.D. Chen, and R.M. Welsh Attrition of bystander CD8 T cells during virus-induced T-cell and interferon responses J Virol 75 2001 5965 5976
14. C.C. Zarozinski, J.M. McNally, B.L. Lohman, K.A. Daniels, and R.M. Welsh Bystander sensitization to activation-induced cell death as a mechanism of virus-induced immune suppression J Virol 74 2000 3650 3658
15. J. Wipasa, H. Xu, A. Stowers, and M.F. Good Apoptotic deletion of Th cells specific for the 19-kDa carboxyl-terminal fragment of merozoite surface protein 1 during malaria infection J Immunol 167 2001 3903 3909
16. J.A. Carrero, B. Calderon, and E.R. Unanue Listeriolysin O from Listeria monocytogenes is a lymphocyte apoptogenic molecule J Immunol 172 2004 4866 4874
17. J.A. Carrero, B. Calderon, and E.R. Unanue Type I interferon sensitizes lymphocytes to apoptosis and reduces resistance to Listeria infection J Exp Med 200 2004 535 540
18. J. Jiang, L.L. Lau, and H. Shen Selective depletion of nonspecific T cells during the early stage of immune responses to infection J Immunol 171 2003 4352 4358
19. +T cell turnover during mycobacterial infection: comparison with Listeria monocytogenes J Immunol 172 2004 3491 3500
20. G.A. Falk, M.W. Kies, and E.C. Alvord Jr. Passive transfer of experimental allergic encephalomyelitis: mechanisms of suppression J Immunol 103 1969 1248 1253
21. +T cells and costimulatory pathways of T-cell activation in protection of non-obese diabetic (NOD) mice from diabetes Immunology 96 1999 600 605
22. T.K. Tarrant, P.B. Silver, J.L. Wahlsten, L.V. Rizzo, C.C. Chan, and B. Wiggery Interlaken 12 protects from a T helper type 1-mediated autoimmune disease experimental autoimmune uveitis, through a mechanism involving interferon gamma, nitric oxide, and apoptosis J Exp Med 189 1999 219 230
23. R. Furlan, E. Brambilla, F. Ruffini, P.L. Poliani, A. Bergami, and P.C. Marconi Intrathecal delivery of IFN-gamma protects C57BL/6 mice from chronic-progressive experimental autoimmune encephalomyelitis by increasing apoptosis of central nervous system-infiltrating lymphocytes J Immunol 167 2001 1821 1829
24. R. Furlan, A. Bergami, D. Cantarella, E. Brambilla, M. Taniguchi, and P. Dellabona Activation of invariant NKT cells by alphaGalCer administration protects mice from MOG35-55-induced EAE: critical roles for administration route and IFN-gamma Eur J Immunol 33 2003 1830 1838
25. A. Weishaupt, S. Jander, W. Bruck, T. Kuhlmann, M. Stienekemeier, and T. Hartung Molecular mechanisms of high-dose antigen therapy in experimental autoimmune encephalomyelitis: rapid induction of Th1-type cytokines and inducible nitric oxide synthase J Immunol 165 2000 7157 7163
26. N. Delasnerie-Laupretre, and A. Alperovitch Epidemiology of multiple sclerosis Rev Prat 41 1991 1884 1887
27. P.E.M. Fine, I.A.M. Carneiro, J.B. Milstien, and C.J. Clements Issues relating to the use of BCG in immunization programmes 1999 World Health Organization Geneva 42 pp
28. M.E. Wilson, H.V. Fineberg, and G.A. Colditz Geographic latitude and the efficacy of Bacillus Calmette-Guerin vaccine Clin Infect Dis 20 1995 982 991
29. M.E. Wilson Applying experiences from trials of Bacille Calmette-Guerin vaccine Clin Infect Dis 30 Suppl 3 2000 S262 S265
30. G.A. Rook, and J.L. Stanford Give us this day our daily germs Immunol Today 19 1998 113 116
31. G.A. Rook Clean living increases more than just atopic disease Immunol Today 21 2000 249 250
32. P. Black Why is the prevalence of allergy and autoimmunity increasing? Trends Immunol 22 2001 354 355
33. G. Ristori, M.G. Buzzi, U. Sabatini, E. Giugni, S. Bastianello, and F. Viselli Use of Bacille Calmette-Guerin (BCG) in multiple sclerosis Neurology 53 1999 1588 1589
34. A. Paolillo, M.G. Buzzi, E. Giugni, U. Sabatini, S. Bastianello, and C. Pozzilli The effect of Bacille Calmette-Guerin on the evolution of new enhancing lesions to hypointense T1 lesions in relapsing remitting MS J Neurol 250 2003 247 248